NMR metabolomics has been applied to a wide range of diseases, with emphasis on cancer.

Most studies have addressed blood serum/plasma and urine, taking advantage of their minimally invasive collection.

Insights into disease pathogenesis and potential new diagnostic markers have emerged.

There is increasing awareness of the need for improved study design and statistical validation.